| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_367e354d968fb9404487a3c21dd2391e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cd03929558acca086b0e941702efb931
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2c05a62c9e5ee5e3a29dc1b1a83f02bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_97104d3dcf60263488a954e627d56523
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_216cb51c4fc33597e8bd304b3982f849 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-00 |
| filingDate |
2011-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2014-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08a89aaa72b7c798e7624d3877b3f1f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55ade25fa01e39281bf9f18d7517176f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a2de87b9532dfe5237724b79fb07518
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fadf5ab31908bb651f5ae3547759f3b |
| publicationDate |
2014-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8883791-B2 |
| titleOfInvention |
N-heteroaryl compounds with cyclic bridging unit for the treatment of parasitic diseases |
| abstract |
This invention relates to certain N-heteroaryl compounds that are generally useful as medicaments, more specifically as medicaments for animals. The medicament can preferably be used for the treatment of helminth infections and the treatment of parasitosis, such as caused by helminth infections. This invention also relates to uses of the compounds to make medicaments and treatments comprising the administration of the compounds to animals in need of the treatments. This invention also relates to the preparation of the N-heteroaryl compounds. Moreover this invention relates to pharmaceutical compositions and kits comprising the compounds. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015087823-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9428477-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11707471-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11701371-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IL-272948-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IL-272948-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2800798-C2 |
| priorityDate |
2010-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |